Patients suffering from disabling hearing loss are often treated via the implantation of an active auditory implant. Even though the use of MRI is often needed in a post-operative follow-up or for the diagnosis of other pathologies. Using MRI in this patient group however raises some concern due to several possible patient risks. The presented work provides an overview of the most commonly occurring adverse events by analyzing data reported to the Food and Drug Administration and the MEDLINE and EMBASE literature databases.
This abstract and the presentation materials are available to members only; a login is required.